369 related articles for article (PubMed ID: 22165685)
1. Bye-bye chiro-inositol - myo-inositol: true progress in the treatment of polycystic ovary syndrome and ovulation induction.
Galletta M; Grasso S; Vaiarelli A; Roseff SJ
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1212-4. PubMed ID: 22165685
[TBL] [Abstract][Full Text] [Related]
2. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.
Nordio M; Proietti E
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):575-81. PubMed ID: 22774396
[TBL] [Abstract][Full Text] [Related]
3. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.
Unfer V; Porcaro G
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):623-31. PubMed ID: 24898153
[TBL] [Abstract][Full Text] [Related]
4. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
Papaleo E; Unfer V; Baillargeon JP; De Santis L; Fusi F; Brigante C; Marelli G; Cino I; Redaelli A; Ferrari A
Gynecol Endocrinol; 2007 Dec; 23(12):700-3. PubMed ID: 17952759
[TBL] [Abstract][Full Text] [Related]
5. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.
Dinicola S; Chiu TT; Unfer V; Carlomagno G; Bizzarri M
J Clin Pharmacol; 2014 Oct; 54(10):1079-92. PubMed ID: 25042908
[TBL] [Abstract][Full Text] [Related]
6. Reflections on inositol(s) for PCOS therapy: steps toward success.
Nestler JE; Unfer V
Gynecol Endocrinol; 2015 Jul; 31(7):501-5. PubMed ID: 26177098
[TBL] [Abstract][Full Text] [Related]
7. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.
Laganà AS; Garzon S; Casarin J; Franchi M; Ghezzi F
Trends Endocrinol Metab; 2018 Nov; 29(11):768-780. PubMed ID: 30270194
[TBL] [Abstract][Full Text] [Related]
8. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
Nestler JE; Jakubowicz DJ; Reamer P; Gunn RD; Allan G
N Engl J Med; 1999 Apr; 340(17):1314-20. PubMed ID: 10219066
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the treatment with D-chiro-inositol on levels of oxidative stress in PCOS patients].
De Leo V; La Marca A; Cappelli V; Stendardi A; Focarelli R; Musacchio MC; Piomboni P
Minerva Ginecol; 2012 Dec; 64(6):531-8. PubMed ID: 23232537
[TBL] [Abstract][Full Text] [Related]
10. Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome.
Nestler JE; Jakubowicz DJ; Iuorno MJ
J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1295-8. PubMed ID: 11117673
[TBL] [Abstract][Full Text] [Related]
11. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
Minozzi M; Nordio M; Pajalich R
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):537-40. PubMed ID: 23467955
[TBL] [Abstract][Full Text] [Related]
12. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.
Colazingari S; Treglia M; Najjar R; Bevilacqua A
Arch Gynecol Obstet; 2013 Dec; 288(6):1405-11. PubMed ID: 23708322
[TBL] [Abstract][Full Text] [Related]
13. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.
Monastra G; Unfer V; Harrath AH; Bizzarri M
Gynecol Endocrinol; 2017 Jan; 33(1):1-9. PubMed ID: 27898267
[TBL] [Abstract][Full Text] [Related]
14. Inositol: history of an effective therapy for Polycystic Ovary Syndrome.
Bizzarri M; Carlomagno G
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1896-903. PubMed ID: 25010620
[TBL] [Abstract][Full Text] [Related]
15. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Unfer V; Carlomagno G; Rizzo P; Raffone E; Roseff S
Eur Rev Med Pharmacol Sci; 2011 Apr; 15(4):452-7. PubMed ID: 21608442
[TBL] [Abstract][Full Text] [Related]
16. The D-chiro-inositol paradox in the ovary.
Carlomagno G; Unfer V; Roseff S
Fertil Steril; 2011 Jun; 95(8):2515-6. PubMed ID: 21641593
[TBL] [Abstract][Full Text] [Related]
17. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios.
Nordio M; Basciani S; Camajani E
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5512-5521. PubMed ID: 31298405
[TBL] [Abstract][Full Text] [Related]
18. Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond.
Facchinetti F; Appetecchia M; Aragona C; Bevilacqua A; Bezerra Espinola MS; Bizzarri M; D'Anna R; Dewailly D; Diamanti-Kandarakis E; Hernández Marín I; Kamenov ZA; Kandaraki E; Laganà AS; Monastra G; Montanino Oliva M; Nestler JE; Orio F; Ozay AC; Papalou O; Pkhaladze L; Porcaro G; Prapas N; Soulage CO; Stringaro A; Wdowiak A; Unfer V
Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):255-274. PubMed ID: 32129111
[No Abstract] [Full Text] [Related]
19. D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.
Galazis N; Galazi M; Atiomo W
Gynecol Endocrinol; 2011 Apr; 27(4):256-62. PubMed ID: 21142777
[TBL] [Abstract][Full Text] [Related]
20. Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.
Facchinetti F; Bizzarri M; Benvenga S; D'Anna R; Lanzone A; Soulage C; Di Renzo GC; Hod M; Cavalli P; Chiu TT; Kamenov ZA; Bevilacqua A; Carlomagno G; Gerli S; Oliva MM; Devroey P
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():72-76. PubMed ID: 26479434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
